TEKTURNA

Peak

aliskiren hemifumarate

NDAORALCAPSULE, PELLETPriority Review
Approved
Nov 2017
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
3

Clinical Trials (3)

NCT01472796Phase 4Unknown

Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension

Started Jul 2011
92 enrolled
Hypertension
NCT01067326Phase 3Terminated

The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis

Started Feb 2010
22 enrolled
Endothelial Dysfunction
NCT01129557Phase 4Terminated

Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Started Sep 2009
46 enrolled
Proteinuric Kidney DiseaseDiabetic NephropathyHypertensive Nephrosclerosis+4 more
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers